Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

2 organizations filed 2 public comments on Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act, at the Food and Drug Administration. The comment window closed 770d ago.

Abstract

Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

Commenters (2)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%
• National Community Pharmacists Associationtrade assoc.

  1 filing · confidence 97%